nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—Benzyl Benzoate—Tamoxifen—pancreatic cancer	0.257	1	CrCrCtD
Fosphenytoin—CYP2B6—Tamoxifen—pancreatic cancer	0.0568	0.108	CbGbCtD
Fosphenytoin—ALB—Erlotinib—pancreatic cancer	0.0473	0.0897	CbGbCtD
Fosphenytoin—CYP2B6—Irinotecan—pancreatic cancer	0.0436	0.0827	CbGbCtD
Fosphenytoin—CYP2C8—Tamoxifen—pancreatic cancer	0.043	0.0816	CbGbCtD
Fosphenytoin—ALB—Irinotecan—pancreatic cancer	0.0427	0.081	CbGbCtD
Fosphenytoin—ALB—Fluorouracil—pancreatic cancer	0.041	0.0778	CbGbCtD
Fosphenytoin—CYP2C8—Erlotinib—pancreatic cancer	0.0366	0.0694	CbGbCtD
Fosphenytoin—CYP2C19—Tamoxifen—pancreatic cancer	0.0361	0.0684	CbGbCtD
Fosphenytoin—CYP2C8—Fluorouracil—pancreatic cancer	0.0317	0.0601	CbGbCtD
Fosphenytoin—CYP2C9—Tamoxifen—pancreatic cancer	0.03	0.0569	CbGbCtD
Fosphenytoin—CYP2B6—Doxorubicin—pancreatic cancer	0.0238	0.0452	CbGbCtD
Fosphenytoin—CYP2C9—Fluorouracil—pancreatic cancer	0.0221	0.0419	CbGbCtD
Fosphenytoin—CYP3A4—Tamoxifen—pancreatic cancer	0.0174	0.0331	CbGbCtD
Fosphenytoin—CYP3A4—Erlotinib—pancreatic cancer	0.0148	0.0281	CbGbCtD
Fosphenytoin—CYP3A4—Irinotecan—pancreatic cancer	0.0134	0.0254	CbGbCtD
Fosphenytoin—CYP3A4—Docetaxel—pancreatic cancer	0.00982	0.0186	CbGbCtD
Fosphenytoin—CYP3A4—Sunitinib—pancreatic cancer	0.00977	0.0185	CbGbCtD
Fosphenytoin—CYP3A4—Doxorubicin—pancreatic cancer	0.00732	0.0139	CbGbCtD
Fosphenytoin—Decreased appetite—Irinotecan—pancreatic cancer	0.000171	0.000795	CcSEcCtD
Fosphenytoin—Dyspnoea—Gemcitabine—pancreatic cancer	0.000171	0.000794	CcSEcCtD
Fosphenytoin—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000171	0.000792	CcSEcCtD
Fosphenytoin—Insomnia—Fluorouracil—pancreatic cancer	0.000171	0.000792	CcSEcCtD
Fosphenytoin—Somnolence—Gemcitabine—pancreatic cancer	0.000171	0.000792	CcSEcCtD
Fosphenytoin—Migraine—Doxorubicin—pancreatic cancer	0.00017	0.00079	CcSEcCtD
Fosphenytoin—Affect lability—Doxorubicin—pancreatic cancer	0.00017	0.00079	CcSEcCtD
Fosphenytoin—Hypokalaemia—Epirubicin—pancreatic cancer	0.00017	0.00079	CcSEcCtD
Fosphenytoin—Paraesthesia—Fluorouracil—pancreatic cancer	0.000169	0.000787	CcSEcCtD
Fosphenytoin—Pruritus—Sunitinib—pancreatic cancer	0.000169	0.000786	CcSEcCtD
Fosphenytoin—Constipation—Irinotecan—pancreatic cancer	0.000168	0.000782	CcSEcCtD
Fosphenytoin—Dyspnoea—Fluorouracil—pancreatic cancer	0.000168	0.000781	CcSEcCtD
Fosphenytoin—Somnolence—Fluorouracil—pancreatic cancer	0.000168	0.000779	CcSEcCtD
Fosphenytoin—Face oedema—Doxorubicin—pancreatic cancer	0.000167	0.000775	CcSEcCtD
Fosphenytoin—Decreased appetite—Gemcitabine—pancreatic cancer	0.000167	0.000774	CcSEcCtD
Fosphenytoin—Dyspepsia—Fluorouracil—pancreatic cancer	0.000166	0.000771	CcSEcCtD
Fosphenytoin—Nausea—Tamoxifen—pancreatic cancer	0.000166	0.00077	CcSEcCtD
Fosphenytoin—Gastritis—Epirubicin—pancreatic cancer	0.000165	0.000768	CcSEcCtD
Fosphenytoin—Muscular weakness—Epirubicin—pancreatic cancer	0.000165	0.000765	CcSEcCtD
Fosphenytoin—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000164	0.000763	CcSEcCtD
Fosphenytoin—Constipation—Gemcitabine—pancreatic cancer	0.000164	0.000762	CcSEcCtD
Fosphenytoin—Nausea—Erlotinib—pancreatic cancer	0.000164	0.000762	CcSEcCtD
Fosphenytoin—Decreased appetite—Fluorouracil—pancreatic cancer	0.000164	0.000761	CcSEcCtD
Fosphenytoin—Mood swings—Doxorubicin—pancreatic cancer	0.000164	0.00076	CcSEcCtD
Fosphenytoin—Diarrhoea—Sunitinib—pancreatic cancer	0.000164	0.00076	CcSEcCtD
Fosphenytoin—Dysgeusia—Docetaxel—pancreatic cancer	0.000163	0.000759	CcSEcCtD
Fosphenytoin—Ataxia—Doxorubicin—pancreatic cancer	0.000163	0.000755	CcSEcCtD
Fosphenytoin—Feeling abnormal—Irinotecan—pancreatic cancer	0.000162	0.000754	CcSEcCtD
Fosphenytoin—Dysphagia—Epirubicin—pancreatic cancer	0.000162	0.00075	CcSEcCtD
Fosphenytoin—Influenza—Epirubicin—pancreatic cancer	0.000162	0.00075	CcSEcCtD
Fosphenytoin—Asthma—Epirubicin—pancreatic cancer	0.000162	0.00075	CcSEcCtD
Fosphenytoin—Back pain—Docetaxel—pancreatic cancer	0.000161	0.000749	CcSEcCtD
Fosphenytoin—Dehydration—Doxorubicin—pancreatic cancer	0.000161	0.000747	CcSEcCtD
Fosphenytoin—Muscle spasms—Docetaxel—pancreatic cancer	0.00016	0.000745	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.00016	0.000741	CcSEcCtD
Fosphenytoin—Dizziness—Sunitinib—pancreatic cancer	0.000158	0.000734	CcSEcCtD
Fosphenytoin—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000158	0.000734	CcSEcCtD
Fosphenytoin—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000158	0.000733	CcSEcCtD
Fosphenytoin—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000157	0.000731	CcSEcCtD
Fosphenytoin—Body temperature increased—Irinotecan—pancreatic cancer	0.000156	0.000723	CcSEcCtD
Fosphenytoin—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000155	0.000722	CcSEcCtD
Fosphenytoin—Bronchitis—Epirubicin—pancreatic cancer	0.000155	0.000721	CcSEcCtD
Fosphenytoin—Anaemia—Docetaxel—pancreatic cancer	0.000154	0.000716	CcSEcCtD
Fosphenytoin—Gastritis—Doxorubicin—pancreatic cancer	0.000153	0.00071	CcSEcCtD
Fosphenytoin—Muscular weakness—Doxorubicin—pancreatic cancer	0.000153	0.000708	CcSEcCtD
Fosphenytoin—Vomiting—Sunitinib—pancreatic cancer	0.000152	0.000706	CcSEcCtD
Fosphenytoin—Body temperature increased—Gemcitabine—pancreatic cancer	0.000152	0.000704	CcSEcCtD
Fosphenytoin—Dysuria—Epirubicin—pancreatic cancer	0.000151	0.000701	CcSEcCtD
Fosphenytoin—Rash—Sunitinib—pancreatic cancer	0.000151	0.0007	CcSEcCtD
Fosphenytoin—Dermatitis—Sunitinib—pancreatic cancer	0.000151	0.000699	CcSEcCtD
Fosphenytoin—Urticaria—Fluorouracil—pancreatic cancer	0.00015	0.000696	CcSEcCtD
Fosphenytoin—Headache—Sunitinib—pancreatic cancer	0.00015	0.000696	CcSEcCtD
Fosphenytoin—Syncope—Docetaxel—pancreatic cancer	0.00015	0.000695	CcSEcCtD
Fosphenytoin—Asthma—Doxorubicin—pancreatic cancer	0.000149	0.000694	CcSEcCtD
Fosphenytoin—Dysphagia—Doxorubicin—pancreatic cancer	0.000149	0.000694	CcSEcCtD
Fosphenytoin—Influenza—Doxorubicin—pancreatic cancer	0.000149	0.000694	CcSEcCtD
Fosphenytoin—Leukopenia—Docetaxel—pancreatic cancer	0.000149	0.000693	CcSEcCtD
Fosphenytoin—Body temperature increased—Fluorouracil—pancreatic cancer	0.000149	0.000692	CcSEcCtD
Fosphenytoin—Palpitations—Docetaxel—pancreatic cancer	0.000147	0.000685	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000147	0.000684	CcSEcCtD
Fosphenytoin—Loss of consciousness—Docetaxel—pancreatic cancer	0.000147	0.000681	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000146	0.000676	CcSEcCtD
Fosphenytoin—Cough—Docetaxel—pancreatic cancer	0.000146	0.000676	CcSEcCtD
Fosphenytoin—Pneumonia—Epirubicin—pancreatic cancer	0.000145	0.000672	CcSEcCtD
Fosphenytoin—Convulsion—Docetaxel—pancreatic cancer	0.000145	0.000671	CcSEcCtD
Fosphenytoin—Hypertension—Docetaxel—pancreatic cancer	0.000144	0.000669	CcSEcCtD
Fosphenytoin—Bronchitis—Doxorubicin—pancreatic cancer	0.000144	0.000667	CcSEcCtD
Fosphenytoin—Arthralgia—Docetaxel—pancreatic cancer	0.000142	0.000659	CcSEcCtD
Fosphenytoin—Myalgia—Docetaxel—pancreatic cancer	0.000142	0.000659	CcSEcCtD
Fosphenytoin—Nausea—Sunitinib—pancreatic cancer	0.000142	0.000659	CcSEcCtD
Fosphenytoin—Renal failure—Epirubicin—pancreatic cancer	0.000142	0.000657	CcSEcCtD
Fosphenytoin—Asthenia—Irinotecan—pancreatic cancer	0.000141	0.000656	CcSEcCtD
Fosphenytoin—Conjunctivitis—Epirubicin—pancreatic cancer	0.00014	0.00065	CcSEcCtD
Fosphenytoin—Dysuria—Doxorubicin—pancreatic cancer	0.00014	0.000649	CcSEcCtD
Fosphenytoin—Dry mouth—Docetaxel—pancreatic cancer	0.000139	0.000645	CcSEcCtD
Fosphenytoin—Sweating—Epirubicin—pancreatic cancer	0.000138	0.000641	CcSEcCtD
Fosphenytoin—Asthenia—Gemcitabine—pancreatic cancer	0.000138	0.000639	CcSEcCtD
Fosphenytoin—Confusional state—Docetaxel—pancreatic cancer	0.000137	0.000637	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000136	0.000633	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000136	0.000632	CcSEcCtD
Fosphenytoin—Epistaxis—Epirubicin—pancreatic cancer	0.000136	0.000631	CcSEcCtD
Fosphenytoin—Pruritus—Gemcitabine—pancreatic cancer	0.000136	0.00063	CcSEcCtD
Fosphenytoin—Infection—Docetaxel—pancreatic cancer	0.000135	0.000628	CcSEcCtD
Fosphenytoin—Sinusitis—Epirubicin—pancreatic cancer	0.000135	0.000627	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000135	0.000626	CcSEcCtD
Fosphenytoin—Diarrhoea—Irinotecan—pancreatic cancer	0.000135	0.000626	CcSEcCtD
Fosphenytoin—Pneumonia—Doxorubicin—pancreatic cancer	0.000134	0.000622	CcSEcCtD
Fosphenytoin—Shock—Docetaxel—pancreatic cancer	0.000134	0.000622	CcSEcCtD
Fosphenytoin—Pruritus—Fluorouracil—pancreatic cancer	0.000133	0.00062	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000133	0.000619	CcSEcCtD
Fosphenytoin—Tachycardia—Docetaxel—pancreatic cancer	0.000133	0.000617	CcSEcCtD
Fosphenytoin—Bradycardia—Epirubicin—pancreatic cancer	0.000132	0.000611	CcSEcCtD
Fosphenytoin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000131	0.00061	CcSEcCtD
Fosphenytoin—Renal failure—Doxorubicin—pancreatic cancer	0.000131	0.000608	CcSEcCtD
Fosphenytoin—Dizziness—Irinotecan—pancreatic cancer	0.00013	0.000605	CcSEcCtD
Fosphenytoin—Anorexia—Docetaxel—pancreatic cancer	0.00013	0.000603	CcSEcCtD
Fosphenytoin—Rhinitis—Epirubicin—pancreatic cancer	0.00013	0.000602	CcSEcCtD
Fosphenytoin—Conjunctivitis—Doxorubicin—pancreatic cancer	0.00013	0.000601	CcSEcCtD
Fosphenytoin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000129	0.000599	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000129	0.000597	CcSEcCtD
Fosphenytoin—Pharyngitis—Epirubicin—pancreatic cancer	0.000128	0.000596	CcSEcCtD
Fosphenytoin—Sweating—Doxorubicin—pancreatic cancer	0.000128	0.000593	CcSEcCtD
Fosphenytoin—Hypotension—Docetaxel—pancreatic cancer	0.000127	0.000591	CcSEcCtD
Fosphenytoin—Epistaxis—Doxorubicin—pancreatic cancer	0.000126	0.000584	CcSEcCtD
Fosphenytoin—Vomiting—Irinotecan—pancreatic cancer	0.000125	0.000581	CcSEcCtD
Fosphenytoin—Sinusitis—Doxorubicin—pancreatic cancer	0.000125	0.00058	CcSEcCtD
Fosphenytoin—Dizziness—Fluorouracil—pancreatic cancer	0.000125	0.000579	CcSEcCtD
Fosphenytoin—Rash—Irinotecan—pancreatic cancer	0.000124	0.000577	CcSEcCtD
Fosphenytoin—Dermatitis—Irinotecan—pancreatic cancer	0.000124	0.000576	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000124	0.000576	CcSEcCtD
Fosphenytoin—Headache—Irinotecan—pancreatic cancer	0.000123	0.000573	CcSEcCtD
Fosphenytoin—Insomnia—Docetaxel—pancreatic cancer	0.000123	0.000572	CcSEcCtD
Fosphenytoin—Paraesthesia—Docetaxel—pancreatic cancer	0.000122	0.000568	CcSEcCtD
Fosphenytoin—Vomiting—Gemcitabine—pancreatic cancer	0.000122	0.000566	CcSEcCtD
Fosphenytoin—Bradycardia—Doxorubicin—pancreatic cancer	0.000122	0.000565	CcSEcCtD
Fosphenytoin—Dyspnoea—Docetaxel—pancreatic cancer	0.000121	0.000564	CcSEcCtD
Fosphenytoin—Somnolence—Docetaxel—pancreatic cancer	0.000121	0.000562	CcSEcCtD
Fosphenytoin—Rash—Gemcitabine—pancreatic cancer	0.000121	0.000562	CcSEcCtD
Fosphenytoin—Dermatitis—Gemcitabine—pancreatic cancer	0.000121	0.000561	CcSEcCtD
Fosphenytoin—Tinnitus—Epirubicin—pancreatic cancer	0.000121	0.00056	CcSEcCtD
Fosphenytoin—Headache—Gemcitabine—pancreatic cancer	0.00012	0.000558	CcSEcCtD
Fosphenytoin—Vomiting—Fluorouracil—pancreatic cancer	0.00012	0.000557	CcSEcCtD
Fosphenytoin—Rhinitis—Doxorubicin—pancreatic cancer	0.00012	0.000557	CcSEcCtD
Fosphenytoin—Dyspepsia—Docetaxel—pancreatic cancer	0.00012	0.000557	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000119	0.000553	CcSEcCtD
Fosphenytoin—Rash—Fluorouracil—pancreatic cancer	0.000119	0.000552	CcSEcCtD
Fosphenytoin—Dermatitis—Fluorouracil—pancreatic cancer	0.000119	0.000552	CcSEcCtD
Fosphenytoin—Pharyngitis—Doxorubicin—pancreatic cancer	0.000119	0.000551	CcSEcCtD
Fosphenytoin—Decreased appetite—Docetaxel—pancreatic cancer	0.000118	0.00055	CcSEcCtD
Fosphenytoin—Headache—Fluorouracil—pancreatic cancer	0.000118	0.000549	CcSEcCtD
Fosphenytoin—Nausea—Irinotecan—pancreatic cancer	0.000117	0.000543	CcSEcCtD
Fosphenytoin—Constipation—Docetaxel—pancreatic cancer	0.000116	0.000541	CcSEcCtD
Fosphenytoin—Chills—Epirubicin—pancreatic cancer	0.000116	0.000539	CcSEcCtD
Fosphenytoin—Nausea—Gemcitabine—pancreatic cancer	0.000114	0.000529	CcSEcCtD
Fosphenytoin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000112	0.000521	CcSEcCtD
Fosphenytoin—Nausea—Fluorouracil—pancreatic cancer	0.000112	0.00052	CcSEcCtD
Fosphenytoin—Tinnitus—Doxorubicin—pancreatic cancer	0.000112	0.000518	CcSEcCtD
Fosphenytoin—Flatulence—Epirubicin—pancreatic cancer	0.000111	0.000515	CcSEcCtD
Fosphenytoin—Tension—Epirubicin—pancreatic cancer	0.00011	0.000513	CcSEcCtD
Fosphenytoin—Dysgeusia—Epirubicin—pancreatic cancer	0.00011	0.000512	CcSEcCtD
Fosphenytoin—Nervousness—Epirubicin—pancreatic cancer	0.000109	0.000507	CcSEcCtD
Fosphenytoin—Back pain—Epirubicin—pancreatic cancer	0.000109	0.000505	CcSEcCtD
Fosphenytoin—Muscle spasms—Epirubicin—pancreatic cancer	0.000108	0.000502	CcSEcCtD
Fosphenytoin—Body temperature increased—Docetaxel—pancreatic cancer	0.000108	0.0005	CcSEcCtD
Fosphenytoin—Chills—Doxorubicin—pancreatic cancer	0.000107	0.000498	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000104	0.000485	CcSEcCtD
Fosphenytoin—Anaemia—Epirubicin—pancreatic cancer	0.000104	0.000483	CcSEcCtD
Fosphenytoin—Agitation—Epirubicin—pancreatic cancer	0.000103	0.00048	CcSEcCtD
Fosphenytoin—Flatulence—Doxorubicin—pancreatic cancer	0.000103	0.000476	CcSEcCtD
Fosphenytoin—Tension—Doxorubicin—pancreatic cancer	0.000102	0.000474	CcSEcCtD
Fosphenytoin—Dysgeusia—Doxorubicin—pancreatic cancer	0.000102	0.000473	CcSEcCtD
Fosphenytoin—Malaise—Epirubicin—pancreatic cancer	0.000101	0.000471	CcSEcCtD
Fosphenytoin—Nervousness—Doxorubicin—pancreatic cancer	0.000101	0.00047	CcSEcCtD
Fosphenytoin—Vertigo—Epirubicin—pancreatic cancer	0.000101	0.000469	CcSEcCtD
Fosphenytoin—Syncope—Epirubicin—pancreatic cancer	0.000101	0.000469	CcSEcCtD
Fosphenytoin—Leukopenia—Epirubicin—pancreatic cancer	0.000101	0.000468	CcSEcCtD
Fosphenytoin—Back pain—Doxorubicin—pancreatic cancer	0.000101	0.000468	CcSEcCtD
Fosphenytoin—Muscle spasms—Doxorubicin—pancreatic cancer	0.0001	0.000465	CcSEcCtD
Fosphenytoin—Palpitations—Epirubicin—pancreatic cancer	9.95e-05	0.000462	CcSEcCtD
Fosphenytoin—Loss of consciousness—Epirubicin—pancreatic cancer	9.89e-05	0.000459	CcSEcCtD
Fosphenytoin—Cough—Epirubicin—pancreatic cancer	9.82e-05	0.000456	CcSEcCtD
Fosphenytoin—Asthenia—Docetaxel—pancreatic cancer	9.77e-05	0.000454	CcSEcCtD
Fosphenytoin—Convulsion—Epirubicin—pancreatic cancer	9.75e-05	0.000453	CcSEcCtD
Fosphenytoin—Hypertension—Epirubicin—pancreatic cancer	9.72e-05	0.000451	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Doxorubicin—pancreatic cancer	9.66e-05	0.000449	CcSEcCtD
Fosphenytoin—Pruritus—Docetaxel—pancreatic cancer	9.64e-05	0.000447	CcSEcCtD
Fosphenytoin—Anaemia—Doxorubicin—pancreatic cancer	9.63e-05	0.000447	CcSEcCtD
Fosphenytoin—Arthralgia—Epirubicin—pancreatic cancer	9.58e-05	0.000445	CcSEcCtD
Fosphenytoin—Myalgia—Epirubicin—pancreatic cancer	9.58e-05	0.000445	CcSEcCtD
Fosphenytoin—Agitation—Doxorubicin—pancreatic cancer	9.57e-05	0.000444	CcSEcCtD
Fosphenytoin—Discomfort—Epirubicin—pancreatic cancer	9.47e-05	0.000439	CcSEcCtD
Fosphenytoin—Malaise—Doxorubicin—pancreatic cancer	9.39e-05	0.000436	CcSEcCtD
Fosphenytoin—Dry mouth—Epirubicin—pancreatic cancer	9.37e-05	0.000435	CcSEcCtD
Fosphenytoin—Vertigo—Doxorubicin—pancreatic cancer	9.36e-05	0.000434	CcSEcCtD
Fosphenytoin—Syncope—Doxorubicin—pancreatic cancer	9.34e-05	0.000434	CcSEcCtD
Fosphenytoin—Leukopenia—Doxorubicin—pancreatic cancer	9.32e-05	0.000433	CcSEcCtD
Fosphenytoin—Diarrhoea—Docetaxel—pancreatic cancer	9.32e-05	0.000433	CcSEcCtD
Fosphenytoin—Confusional state—Epirubicin—pancreatic cancer	9.26e-05	0.00043	CcSEcCtD
Fosphenytoin—Palpitations—Doxorubicin—pancreatic cancer	9.2e-05	0.000427	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Epirubicin—pancreatic cancer	9.19e-05	0.000426	CcSEcCtD
Fosphenytoin—Loss of consciousness—Doxorubicin—pancreatic cancer	9.15e-05	0.000425	CcSEcCtD
Fosphenytoin—Infection—Epirubicin—pancreatic cancer	9.13e-05	0.000424	CcSEcCtD
Fosphenytoin—Cough—Doxorubicin—pancreatic cancer	9.09e-05	0.000422	CcSEcCtD
Fosphenytoin—Shock—Epirubicin—pancreatic cancer	9.04e-05	0.00042	CcSEcCtD
Fosphenytoin—Convulsion—Doxorubicin—pancreatic cancer	9.02e-05	0.000419	CcSEcCtD
Fosphenytoin—Dizziness—Docetaxel—pancreatic cancer	9.01e-05	0.000418	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Epirubicin—pancreatic cancer	8.99e-05	0.000418	CcSEcCtD
Fosphenytoin—Hypertension—Doxorubicin—pancreatic cancer	8.99e-05	0.000417	CcSEcCtD
Fosphenytoin—Tachycardia—Epirubicin—pancreatic cancer	8.97e-05	0.000416	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Epirubicin—pancreatic cancer	8.88e-05	0.000412	CcSEcCtD
Fosphenytoin—Arthralgia—Doxorubicin—pancreatic cancer	8.87e-05	0.000412	CcSEcCtD
Fosphenytoin—Myalgia—Doxorubicin—pancreatic cancer	8.87e-05	0.000412	CcSEcCtD
Fosphenytoin—Discomfort—Doxorubicin—pancreatic cancer	8.76e-05	0.000407	CcSEcCtD
Fosphenytoin—Anorexia—Epirubicin—pancreatic cancer	8.76e-05	0.000406	CcSEcCtD
Fosphenytoin—Dry mouth—Doxorubicin—pancreatic cancer	8.67e-05	0.000403	CcSEcCtD
Fosphenytoin—Vomiting—Docetaxel—pancreatic cancer	8.66e-05	0.000402	CcSEcCtD
Fosphenytoin—Rash—Docetaxel—pancreatic cancer	8.59e-05	0.000399	CcSEcCtD
Fosphenytoin—Hypotension—Epirubicin—pancreatic cancer	8.58e-05	0.000398	CcSEcCtD
Fosphenytoin—Dermatitis—Docetaxel—pancreatic cancer	8.58e-05	0.000398	CcSEcCtD
Fosphenytoin—Confusional state—Doxorubicin—pancreatic cancer	8.57e-05	0.000398	CcSEcCtD
Fosphenytoin—Headache—Docetaxel—pancreatic cancer	8.53e-05	0.000396	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Doxorubicin—pancreatic cancer	8.5e-05	0.000395	CcSEcCtD
Fosphenytoin—Infection—Doxorubicin—pancreatic cancer	8.44e-05	0.000392	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	8.37e-05	0.000389	CcSEcCtD
Fosphenytoin—Shock—Doxorubicin—pancreatic cancer	8.36e-05	0.000388	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Doxorubicin—pancreatic cancer	8.32e-05	0.000386	CcSEcCtD
Fosphenytoin—Insomnia—Epirubicin—pancreatic cancer	8.31e-05	0.000386	CcSEcCtD
Fosphenytoin—Tachycardia—Doxorubicin—pancreatic cancer	8.3e-05	0.000385	CcSEcCtD
Fosphenytoin—Paraesthesia—Epirubicin—pancreatic cancer	8.25e-05	0.000383	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Doxorubicin—pancreatic cancer	8.22e-05	0.000381	CcSEcCtD
Fosphenytoin—Dyspnoea—Epirubicin—pancreatic cancer	8.19e-05	0.00038	CcSEcCtD
Fosphenytoin—Somnolence—Epirubicin—pancreatic cancer	8.17e-05	0.000379	CcSEcCtD
Fosphenytoin—Anorexia—Doxorubicin—pancreatic cancer	8.1e-05	0.000376	CcSEcCtD
Fosphenytoin—Nausea—Docetaxel—pancreatic cancer	8.09e-05	0.000376	CcSEcCtD
Fosphenytoin—Dyspepsia—Epirubicin—pancreatic cancer	8.09e-05	0.000375	CcSEcCtD
Fosphenytoin—Decreased appetite—Epirubicin—pancreatic cancer	7.99e-05	0.000371	CcSEcCtD
Fosphenytoin—Hypotension—Doxorubicin—pancreatic cancer	7.94e-05	0.000369	CcSEcCtD
Fosphenytoin—Constipation—Epirubicin—pancreatic cancer	7.86e-05	0.000365	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	7.74e-05	0.000359	CcSEcCtD
Fosphenytoin—Insomnia—Doxorubicin—pancreatic cancer	7.69e-05	0.000357	CcSEcCtD
Fosphenytoin—Paraesthesia—Doxorubicin—pancreatic cancer	7.63e-05	0.000354	CcSEcCtD
Fosphenytoin—Dyspnoea—Doxorubicin—pancreatic cancer	7.58e-05	0.000352	CcSEcCtD
Fosphenytoin—Feeling abnormal—Epirubicin—pancreatic cancer	7.57e-05	0.000351	CcSEcCtD
Fosphenytoin—Somnolence—Doxorubicin—pancreatic cancer	7.56e-05	0.000351	CcSEcCtD
Fosphenytoin—Dyspepsia—Doxorubicin—pancreatic cancer	7.48e-05	0.000347	CcSEcCtD
Fosphenytoin—Decreased appetite—Doxorubicin—pancreatic cancer	7.39e-05	0.000343	CcSEcCtD
Fosphenytoin—Urticaria—Epirubicin—pancreatic cancer	7.3e-05	0.000339	CcSEcCtD
Fosphenytoin—Constipation—Doxorubicin—pancreatic cancer	7.27e-05	0.000337	CcSEcCtD
Fosphenytoin—Body temperature increased—Epirubicin—pancreatic cancer	7.26e-05	0.000337	CcSEcCtD
Fosphenytoin—Feeling abnormal—Doxorubicin—pancreatic cancer	7e-05	0.000325	CcSEcCtD
Fosphenytoin—Urticaria—Doxorubicin—pancreatic cancer	6.75e-05	0.000313	CcSEcCtD
Fosphenytoin—Body temperature increased—Doxorubicin—pancreatic cancer	6.72e-05	0.000312	CcSEcCtD
Fosphenytoin—Asthenia—Epirubicin—pancreatic cancer	6.59e-05	0.000306	CcSEcCtD
Fosphenytoin—Pruritus—Epirubicin—pancreatic cancer	6.5e-05	0.000302	CcSEcCtD
Fosphenytoin—Diarrhoea—Epirubicin—pancreatic cancer	6.28e-05	0.000292	CcSEcCtD
Fosphenytoin—Asthenia—Doxorubicin—pancreatic cancer	6.1e-05	0.000283	CcSEcCtD
Fosphenytoin—Dizziness—Epirubicin—pancreatic cancer	6.07e-05	0.000282	CcSEcCtD
Fosphenytoin—Pruritus—Doxorubicin—pancreatic cancer	6.01e-05	0.000279	CcSEcCtD
Fosphenytoin—Vomiting—Epirubicin—pancreatic cancer	5.84e-05	0.000271	CcSEcCtD
Fosphenytoin—Diarrhoea—Doxorubicin—pancreatic cancer	5.82e-05	0.00027	CcSEcCtD
Fosphenytoin—Rash—Epirubicin—pancreatic cancer	5.79e-05	0.000269	CcSEcCtD
Fosphenytoin—Dermatitis—Epirubicin—pancreatic cancer	5.79e-05	0.000269	CcSEcCtD
Fosphenytoin—Headache—Epirubicin—pancreatic cancer	5.75e-05	0.000267	CcSEcCtD
Fosphenytoin—Dizziness—Doxorubicin—pancreatic cancer	5.62e-05	0.000261	CcSEcCtD
Fosphenytoin—Nausea—Epirubicin—pancreatic cancer	5.46e-05	0.000253	CcSEcCtD
Fosphenytoin—Vomiting—Doxorubicin—pancreatic cancer	5.4e-05	0.000251	CcSEcCtD
Fosphenytoin—Rash—Doxorubicin—pancreatic cancer	5.36e-05	0.000249	CcSEcCtD
Fosphenytoin—Dermatitis—Doxorubicin—pancreatic cancer	5.35e-05	0.000249	CcSEcCtD
Fosphenytoin—Headache—Doxorubicin—pancreatic cancer	5.32e-05	0.000247	CcSEcCtD
Fosphenytoin—Nausea—Doxorubicin—pancreatic cancer	5.05e-05	0.000234	CcSEcCtD
